Related content

Prognostic Significance of Postoperative Morbidities in Patients With Advanced Epithelial Ovarian Cancer Treated With Neoadjuvant Chemotherapy and Delayed Primary Surgical Debulking

By Le Tien   Alshaikh Ghadeer   Hopkins Laura   Faught Wylam   Fung Michael  

Annals of Surgical Oncology, Vol. 13, Iss. 12, 2006-12 ,pp. : 1711-1716

Springer Publishing Company

Access to resources Recommend Favorite

Neoadjuvant chemotherapy followed by surgery and adjuvant chemotherapy in patients with primarily unresectable, advanced-stage ovarian cancer

By Mazzeo F.   Berliere M.   Kerger J.   Squifflet J.   Duck L.   D'Hondt V.   Humblet Y.   Donnez J.   Machiels J.-P.  

Gynecologic Oncology, Vol. 90, Iss. 1, 2003-07 ,pp. : 163-169

Elsevier

Access to resources Recommend Favorite

Omental Chemotherapy Effects as a Prognostic Factor in Ovarian Cancer Patients Treated With Neoadjuvant Chemotherapy and Delayed Primary Surgical Debulking

By Le Tien   Williams Kona   Senterman Mary   Hopkins Laura   Faught Wylam   Fung-Kee-Fung M.  

Annals of Surgical Oncology, Vol. 14, Iss. 9, 2007-09 ,pp. : 2649-2653

Springer Publishing Company

Access to resources Recommend Favorite

Neoadjuvant Chemotherapy or Primary Debulking Surgery in Advanced Ovarian Carcinoma: A Retrospective Analysis of 285 Patients

By Vergote I.   De Wever I.   Tjalma W.   Van Gramberen M.   Decloedt J.   van Dam P.  

Gynecologic Oncology, Vol. 71, Iss. 3, 1998-12 ,pp. : 431-436

Elsevier

Access to resources Recommend Favorite

Predicting toxicity in advanced lung cancer patients treated with platinum-based chemotherapy

By Ioannidis Georgios   Souglakos John   Georgoulias Vassilis  

Lung Cancer Management, Vol. 2, Iss. 4, 2013-08 ,pp. : 281-293

Future Medicine

Access to resources Recommend Favorite